logo

Roche Holding Ag (RHHBY)



Trade RHHBY now with
  Date
  Headline
10/14/2019 1:07:38 AM Genentech Says Phase III PEMPHIX Study Of Rituxan Meets Primary Endpoint
9/30/2019 10:57:52 AM Roche Presents Positive Phase III Results For Tecentriq-platinum-based Chemotherapy In Untreated Advanced Bladder Cancer
9/30/2019 2:36:19 AM Genentech To Report Positive Result From Single-arm Cohort Of Phase II/III BFAST
9/30/2019 1:07:06 AM Roche Says FDA Approved Rituxan In Combination With Glucocorticoids
9/30/2019 1:06:00 AM Roche Extends Tender Offer For Shares Of Spark Therapeutics To Oct 30
9/27/2019 8:09:39 AM Roche To Present Results From Phase Ib Study Evaluating Tecentriq Plus Avastin
9/25/2019 2:09:27 AM CMA Invites Comments On Roche / Spark Transaction
9/23/2019 1:04:18 AM Roche Says Results From No. Of Studies Across Comprehensive Oncology Portfolio
9/20/2019 1:03:14 AM Roche: FDA Approves Cobas Babesia Test For Use On Cobas 6800/8800 Systems
9/18/2019 1:06:32 AM Roche Says FDA Granted Breakthrough Therapy Designation To Gazyva
9/18/2019 1:02:42 AM FDA Grants Breakthrough Therapy Designation For Genentech's Gazyva
9/16/2019 1:03:27 AM Roche Receives FDA Clearance For Cobas Pro Integrated Solutions
  
 
>